Nebulized Glycopyrronium and  Formoterol, Budesonide Aerosol Aerodynamic Assessment With Vibrating Mesh and Compressor Air Nebulizer: Anderson Cascade Impactor Study

Menon, Mala; Naik, Isha; Rajawat, Gopal Singh; Nagarsenker, Mangal S.; Korukonda, Krishnaprasad

doi:10.22270/jddt.v9i6.3465

Cited by 3 publications

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In our study, 40.8% of the aerosol therapy was given in combination; however, almost 90% were compatible as per the physio-chemical studies of drugs. [ 16 17 18 ]…”

Section: Discussionmentioning

confidence: 99%

Aerosol drug therapy in critically ill patients (Aero-in-ICU study): A multicentre prospective observational cohort study

Singhal,

Gurjar,

Sahoo

et al. 2024

Lung India

View full text Add to dashboard Cite

Background: In recent years, a significant understanding of delivering optimal aerosol therapy and the availability of various drugs and devices have led to an increase in its use in clinical practice. There are only a few studies available regarding their use in critically ill patients from a few parts of the world. We aimed to study the practice pattern of aerosol therapy in critically ill patients from Indian intensive care units (ICUs). Methods: After ethical approval, this multi-centric prospective observational study was performed over a study period of four weeks. Newly admitted adult patients considered who had an artificial airway and/or ventilation (including non-invasive). Patients were followed up for the next 14 days or until ICU discharge/death (whichever came first) for details of each aerosol therapy, including ongoing respiratory support, drug type, and aerosol-generating device. Results: From the nine participating centers across India, 218 patients were enrolled. Of 218 enrolled patients, 72.48% received 4884 aerosols with 30.91 ± 27.15 (95%CI: 26.6-35.1) aerosols per patient over 1108 patient days. Approximately 62.7% during IMV, 30.2% during NIV, 2.3% in spontaneously breathing patients with an artificial airway during weaning, and 4.7% were given without an artificial airway after weaning or decannulation. In 59%, a single drug was used, and bronchodilators were the most frequent. The jet nebulizer was the most common, followed by the ultrasonic and vibrating mesh aerosol generator. The ventilator setting was changed in only 6.6% of the aerosol sessions with IMV and none with NIV. Conclusion: Aerosol therapy is frequently used with a wide variation in practices; bronchodilators are the most commonly used drugs, and jet nebulizers are the most widely used.

show abstract

“…In our study, 40.8% of the aerosol therapy was given in combination; however, almost 90% were compatible as per the physio-chemical studies of drugs. [ 16 17 18 ]…”

Section: Discussionmentioning

confidence: 99%